HHMI to Award More than $1 Billion to Promote Equity in Research

A new program will provide 150 early-career scientists committed to advancing diversity, inclusion, and equity up to $8.6 million each.

Written byAndy Carstens
| 2 min read
Outlines of people in multiple colors
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Howard Hughes Medical Institute (HHMI) has announced a nearly $1.3 billion program for early-career scientists in an effort to increase diversity in the scientific workforce.

“For academic science to thrive in an increasingly diverse world, we need to attract and support scientists from a wide variety of racial and ethnic backgrounds,” says HHMI president Erin O’Shea in the institute’s announcement. “Early career faculty play a key role because they are the leaders of tomorrow.”

The new program, called the Freeman Hrabowski Scholars Program, is named in honor of the University of Maryland, Baltimore County’s outgoing president, Freeman A. Hrabowski III, who has worked to increase the number of scientists, engineers, and physicians from marginalized backgrounds, according to the institute’s announcement.

HHMI’s aim for the new program, it says, is to bolster future leaders’ scientific research as they build labs with more equitable and inclusive working environments.

The program is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Andrew Carstens

    Andy Carstens is a freelance science journalist who is a current contributor and past intern at The Scientist. He has a bachelor’s degree in chemical engineering from the Georgia Institute of Technology and a master’s in science writing from Johns Hopkins University. Andy’s work has previously appeared in AudubonSlateThem, and Aidsmap. View his full portfolio at www.andycarstens.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies